{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T04:27:43Z","timestamp":1726460863735},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.atherosclerosis.2005.07.017","type":"journal-article","created":{"date-parts":[[2005,8,20]],"date-time":"2005-08-20T11:18:35Z","timestamp":1124536715000},"page":"86-91","source":"Crossref","is-referenced-by-count":9,"title":["Severe hyperlipidemia causes impaired renin\u2013angiotensin system function in apolipoprotein E deficient mice"],"prefix":"10.1016","volume":"186","author":[{"given":"Lucia","family":"Mazzolai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Korber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karima","family":"Bouzourene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrg","family":"Nussberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Stamenkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hayoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.0000140269.55873.7b","article-title":"Endogenous angiotensin II Induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE\u2212\/\u2212 mice","author":"Mazzolai","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib4","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1126\/science.6795720","article-title":"Type III hyperlipoproteinemia associated with apolipoprotein E deficiency","volume":"214","author":"Ghiselli","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib5","first-page":"51","article-title":"Type 3 hyperlipoproteinemia with mesangial foam cells in renal glomeruli","volume":"98","author":"Amatruda","year":"1974","journal-title":"Arch Pathol"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07104.x","article-title":"Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease","volume":"71","author":"Attman","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib7","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1046\/j.1523-1755.2000.07503.x","article-title":"The role of lipids in renal disease: future challenges","volume":"75","author":"Keane","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","article-title":"Effect of lipid reduction on the progression of renal disease: a meta-analysis","volume":"59","author":"Fried","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib9","first-page":"307","article-title":"Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment","volume":"111","author":"Stevenson","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/014107680009300406","article-title":"Lipid abnormalities in renal disease","volume":"93","author":"Majumdar","year":"2000","journal-title":"J R Soc Med"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.1991.22","article-title":"Lipid abnormalities in renal disease","volume":"39","author":"Appel","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib12","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/ndt\/12.9.1908","article-title":"Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency","volume":"12","author":"Samuelsson","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib13","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","article-title":"Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study","volume":"58","author":"Muntner","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.HYP.29.4.1025","article-title":"Two-kidney, one clip and one-kidney, one clip hypertension in mice","volume":"29","author":"Wiesel","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2005.07.017_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005344-198701000-00007","article-title":"Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers","volume":"9","author":"Nussberger","year":"1987","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915005004703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915005004703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T16:36:11Z","timestamp":1552840571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915005004703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0021915005004703"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.07.017","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}